| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Departments of Pathobiology and 2 Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; 3 Louis-Jeantet Skin Cancer Lab, Department of Dermatology, Geneva University Medical School, Geneva, Switzerland; 4 IVL BioService, Saint-Barthélémy, Le Gua, France; and 5 Division of Developmental Biology, Childrens Hospital Research Foundation Cincinnati, Ohio
Effective treatment of malignant carcinomas requires identification of proteins regulating epithelial cell proliferation. To this end, we compared gene expression profiles in murine colonocytes and their c-Myc-transformed counterparts, which possess enhanced proliferative potential. A surprisingly short list of deregulated genes included the cDNA for clusterin, an extracellular glycoprotein without a firmly established function. We had previously demonstrated that in organs such as skin, clusterin expression is restricted to differentiating but not proliferating cell layers, suggesting a possible negative role in cell division. Indeed, its transient overexpression in Myc-transduced colonocytes decreased cell accumulation. Furthermore, clusterin was down-regulated in rapidly dividing human keratinocytes infected with a Myc-encoding adenovirus. Its knockdown via antisense RNA in neoplastic epidermoid cells enhanced proliferation. Finally, recombinant human clusterin suppressed, in a dose-dependent manner, DNA replication in keratinocytes and other cells of epithelial origin. Thus, clusterin appears to be an inhibitor of epithelial cell proliferation in vitro. To determine whether it also affects neoplastic growth in vivo, we compared wild-type and clusterin-null mice with respect to their sensitivity to 7, 12-dimethylbenz(a)anthracene /12-Otetradecanoylphorbol-13-acetate (DMBA/TPA)-induced skin carcinogenesis. We observed that the mean number of papillomas/mouse was higher in clusterin-null animals. Moreover, these papillomas did not regress as readily as in wild-type mice and persisted beyond week 35. The rate of progression toward squamous cell carcinoma was not altered, although those developing in clusterin-null mice were on average better differentiated. These data suggest that clusterin not only suppresses epithelial cell proliferation in vitro but also interferes with the promotion stage of skin carcinogenesis.
This article has been cited by other articles:
![]() |
O. Chayka, D. Corvetta, M. Dews, A. E. Caccamo, I. Piotrowska, G. Santilli, S. Gibson, N. J. Sebire, N. Himoudi, M. D. Hogarty, et al. Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas J Natl Cancer Inst, May 6, 2009; 101(9): 663 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Trougakos, J. Y. Djeu, E. S. Gonos, and D. A. Boothman Advances and Challenges in Basic and Translational Research on Clusterin Cancer Res., January 15, 2009; 69(2): 403 - 406. [Full Text] [PDF] |
||||
![]() |
I. P. Trougakos, M. Lourda, M. H. Antonelou, D. Kletsas, V. G. Gorgoulis, I. S. Papassideri, Y. Zou, L. H. Margaritis, D. A. Boothman, and E. S. Gonos Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex Clin. Cancer Res., January 1, 2009; 15(1): 48 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Wise, R. J. DeBerardinis, A. Mancuso, N. Sayed, X.-Y. Zhang, H. K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S. B. McMahon, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction PNAS, December 2, 2008; 105(48): 18782 - 18787. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jo, Y. Jia, K. K. Subramanian, H. Hattori, and H. R. Luo Cancer Cell-Derived Clusterin Modulates the Phosphatidylinositol 3'-Kinase-Akt Pathway through Attenuation of Insulin-Like Growth Factor 1 during Serum Deprivation Mol. Cell. Biol., July 1, 2008; 28(13): 4285 - 4299. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jovanovic, A.-S. Dugast, J.-M. Heslan, J. Ashton-Chess, M. Giral, N. Degauque, A. Moreau, A. Pallier, E. Chiffoleau, D. Lair, et al. Implication of Matrix Metalloproteinase 7 and the Noncanonical Wingless-Type Signaling Pathway in a Model of Kidney Allograft Tolerance Induced by the Administration of Anti-Donor Class II Antibodies J. Immunol., February 1, 2008; 180(3): 1317 - 1325. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |